Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Biol Chem ; 288(26): 18789-802, 2013 Jun 28.
Artículo en Inglés | MEDLINE | ID: mdl-23625922

RESUMEN

Molecules that simultaneously inhibit independent or co-dependent proinflammatory pathways may have advantages over conventional monotherapeutics. OmCI is a bifunctional protein derived from blood-feeding ticks that specifically prevents complement (C)-mediated C5 activation and also sequesters leukotriene B4 (LTB4) within an internal binding pocket. Here, we examined the effect of LTB4 binding on OmCI structure and function and investigated the relative importance of C-mediated C5 activation and LTB4 in a mouse model of immune complex-induced acute lung injury (IC-ALI). We describe two crystal structures of bacterially expressed OmCI: one binding a C16 fatty acid and the other binding LTB4 (C20). We show that the C5 and LTB4 binding activities of the molecule are independent of each other and that OmCI is a potent inhibitor of experimental IC-ALI, equally dependent on both C5 inhibition and LTB4 binding for full activity. The data highlight the importance of LTB4 in IC-ALI and activation of C5 by the complement pathway C5 convertase rather than by non-C proteases. The findings suggest that dual inhibition of C5 and LTB4 may be useful for treatment of human immune complex-dependent diseases.


Asunto(s)
Lesión Pulmonar Aguda/metabolismo , Complejo Antígeno-Anticuerpo/farmacología , Proteínas de Artrópodos/farmacología , Proteínas Portadoras/farmacología , Lipocalinas/farmacología , Lesión Pulmonar Aguda/inmunología , Lesión Pulmonar Aguda/terapia , Animales , Proteínas de Artrópodos/metabolismo , Proteínas Portadoras/metabolismo , Cromatografía de Gases , Complemento C5/metabolismo , Eicosanoides/metabolismo , Ácidos Grasos/metabolismo , Técnicas para Inmunoenzimas , Leucotrieno B4/metabolismo , Lipocalinas/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Proteínas Recombinantes/metabolismo , Ovinos , Resonancia por Plasmón de Superficie , Trombina/metabolismo
2.
J Mol Microbiol Biotechnol ; 4(3): 269-76, 2002 May.
Artículo en Inglés | MEDLINE | ID: mdl-11931558

RESUMEN

Formate is the signature compound in the anaerobic metabolism of Escherichia coli and other enterobacteria. Its synthesis and degradation is integrated in a net-work of metabolic routes which are elegantly regulated to adjust the carbon flux to the metabolic needs. This review summarises the information on the biochemistry of synthesis and degradation of formate, on the genetics of the members of the regulon and on the mechanism underlying the regulation.


Asunto(s)
Enterobacteriaceae/genética , Formiatos/metabolismo , Regulón , Enterobacteriaceae/metabolismo , Escherichia coli/genética , Escherichia coli/metabolismo , Regulación Bacteriana de la Expresión Génica , Regulón/genética , Regulón/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA